Sign up to create alerts for Instruments,
Economic Events and content by followed authors
Free Sign Up Already have an account? Sign In
Quotes
All Instrument Types
- All Instrument Types
- Indices
- Equities
- ETFs
- Funds
- Commodities
- Currencies
- Crypto
- Bonds
- Certificates
Please try another search
🏰✨ This Week: Disney Q3 earnings report - is now the right time to buy?
Ask WarrenAI
Selectra J. Lamarck Biotech Class B (0P0000SCS3)
Add to/Remove from a Portfolio
Add to Watchlist
349.850
-6.070
-1.71%
07/11 - Closed. Currency in EUR
Type:
Fund
Market:
Luxembourg
Issuer:
SELECTRA MANAGEMENT COMPANY S.A.
ISIN:
LU0574994512
Asset Class:
Equity
- Morningstar Rating:
- Total Assets: 75.03M
Selectra J. Lamarck Biotech Class B
349.850
-6.070
-1.71%
- Overview
- Profile
- Historical Data
- Holdings
0P0000SCS3 Overview
Find basic information about the Selectra J. Lamarck Biotech Class B mutual fund such as total assets, risk rating, Min. investment, market cap and category. Learn about the fund's agencies rating and risk rating, transparent information about the fund's management personal, policies of invested allocation and diversification, past performance. In addition we provide you related news, analysis tools, interactive charts and analysis articles. You may add 0P0000SCS3 MF to your portfolio and watchlist to keep track with the fund's performance and users commentary.
Loading
Last Update:
Rating
1-Year Change3.38%
Prev. Close355.92
Risk Rating
TTM Yield0%
ROE - 4.80%
IssuerSELECTRA MANAGEMENT COMPANY S.A.
TurnoverN/A
ROA - 9.95%
Inception DateJan 10, 2011
Total Assets75.03M
Expenses2.50%
Min. Investment5,000
Market Cap7.68B
CategorySector Equity Biotechnology
What is your sentiment on Selectra J. Lamarck Biotech Class B?
Members' Sentiments:
or
Market is currently closed. Voting is open during market hours.
Performance
| YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
|---|---|---|---|---|---|---|
| Growth of 1000 | 1197 | 1158 | 1136 | 809 | 1004 | 1331 |
| Fund Return | 19.68% | 15.84% | 13.57% | -6.8% | 0.07% | 2.9% |
| Place in category | 61 | 166 | 70 | 149 | 100 | 57 |
| % in Category | 20 | 77 | 32 | 90 | 80 | 66 |
Top Equity Funds by J. Lamarck Asset Management S.A.
| Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
|---|---|---|---|---|---|---|
| Selectra J Lamarck Biotech Class A | 75.03M | 20.85 | -5.63 | 3.96 |
Top Funds for Sector Equity Biotechnology Category
| Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
|---|---|---|---|---|---|---|
| Pictet Biotech I EUR | 1.7B | 22.57 | 10.76 | 5.47 | ||
| Pictet Biotech P EUR | 1.7B | 21.67 | 9.78 | 4.57 | ||
| Pictet Biotech R EUR | 1.7B | 20.95 | 9.00 | 3.84 | ||
| LU1120766388 | 1.61B | 15.40 | 7.64 | 6.91 | ||
| FCP MEDICAL BioHealth-Trends EUR | 738.38M | 19.44 | 12.32 | 9.84 |
Top Holdings
| Name | ISIN | Weight % | Last | Change % | |
|---|---|---|---|---|---|
| Ionis Pharma | US4622221004 | 9.71 | 69.54 | -5.45% | |
| Biogen | US09062X1037 | 9.29 | 156.26 | +0.48% | |
| Crispr Therapeutics | CH0334081137 | 5.54 | 54.58 | -0.98% | |
| Alnylam | US02043Q1076 | 5.13 | 441.70 | -0.23% | |
| Swedish Orphan Biovitrum | SE0000872095 | 4.52 | 328.60 | +0.80% |
Technical Summary
| Type | Daily | Weekly | Monthly |
|---|---|---|---|
| Moving Averages | Neutral | Buy | Buy |
| Technical Indicators | Strong Sell | Strong Buy | Strong Buy |
| Summary | Sell | Strong Buy | Strong Buy |
Write your thoughts about Selectra J. Lamarck Biotech Class B
Are you sure you want to delete this chart?
Delete Cancel
Replace the attached chart with a new chart ?
Replace Cancel
Comment Guidelines
Add Chart to Comment
Confirm Block
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
Report this comment
I feel that this comment is:
Comment flagged
Thank You!
Your report has been sent to our moderators for review